These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 20018350)
1. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Eisner BH; Eisenberg ML; Stoller ML Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350 [TBL] [Abstract][Full Text] [Related]
2. Body size and 24-hour urine composition. Taylor EN; Curhan GC Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145 [TBL] [Abstract][Full Text] [Related]
3. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis. Eisner BH; Eisenberg ML; Stoller ML J Urol; 2009 Nov; 182(5):2330-3. PubMed ID: 19758639 [TBL] [Abstract][Full Text] [Related]
4. Influence of body mass index on quantitative 24-hour urine chemistry studies in children with nephrolithiasis. Eisner BH; Eisenberg ML; Stoller ML J Urol; 2009 Sep; 182(3):1142-5. PubMed ID: 19625057 [TBL] [Abstract][Full Text] [Related]
5. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers. Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490 [TBL] [Abstract][Full Text] [Related]
6. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919 [TBL] [Abstract][Full Text] [Related]
7. The effects of ambient temperature, humidity and season of year on urine composition in patients with nephrolithiasis. Eisner BH; Sheth S; Herrick B; Pais VM; Sawyer M; Miller N; Hurd KJ; Humphreys MR BJU Int; 2012 Dec; 110(11 Pt C):E1014-7. PubMed ID: 22578009 [TBL] [Abstract][Full Text] [Related]
8. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis. Eisner BH; Porten SP; Bechis SK; Stoller ML J Urol; 2010 Feb; 183(2):576-9. PubMed ID: 20018328 [TBL] [Abstract][Full Text] [Related]
9. Seasonal variations in urinary risk factors among patients with nephrolithiasis. Stuart RO 2nd ; Hill K; Poindexter J; Pak CY J Lithotr Stone Dis; 1991 Jan; 3(1):18-27. PubMed ID: 11536932 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and low urinary citrate excretion in calcium stone formers. Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967 [TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia and kidney stone risk. Torricelli FC; De SK; Gebreselassie S; Li I; Sarkissian C; Monga M J Urol; 2014 Mar; 191(3):667-72. PubMed ID: 24055417 [TBL] [Abstract][Full Text] [Related]
12. Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587 [TBL] [Abstract][Full Text] [Related]
13. 24-Hour Urinary Chemistries and Kidney Stone Risk. Ferraro PM; Taylor EN; Curhan GC Am J Kidney Dis; 2024 Aug; 84(2):164-169. PubMed ID: 38583757 [TBL] [Abstract][Full Text] [Related]
14. The role of overweight and obesity in calcium oxalate stone formation. Siener R; Glatz S; Nicolay C; Hesse A Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848 [TBL] [Abstract][Full Text] [Related]
15. The most important metabolic risk factors in recurrent urinary stone formers. Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S Urol J; 2011; 8(2):99-106. PubMed ID: 21656467 [TBL] [Abstract][Full Text] [Related]
16. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. Eisner BH; Porten SP; Bechis SK; Stoller ML J Urol; 2010 Jun; 183(6):2244-8. PubMed ID: 20400141 [TBL] [Abstract][Full Text] [Related]
17. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681 [TBL] [Abstract][Full Text] [Related]
18. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. Zerwekh JE; Odvina CV; Wuermser LA; Pak CY J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313 [TBL] [Abstract][Full Text] [Related]
19. [Sodium excretion in children with lithogenic disorders]. Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402 [TBL] [Abstract][Full Text] [Related]
20. Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis. Arrabal-Polo MA; Arrabal-Martin M; Arias-Santiago S; Garrido-Gomez J; Poyatos-Andujar A; Zuluaga-Gomez A BJU Int; 2013 Apr; 111(4):622-7. PubMed ID: 22757744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]